Matthew Ros

2016

In 2016, Matthew Ros earned a total compensation of $1.5M as Chief Strategy and Business Officer at Epizyme.

Compensation breakdown

Bonus$65,000
Non-Equity Incentive Plan$86,864
Option Awards$1,128,422
Salary$237,500
Other$2,837
Total$1,520,623

Ros received $1.1M in option awards, accounting for 74% of the total pay in 2016.

Ros also received $65K in bonus, $86.9K in non-equity incentive plan, $237.5K in salary and $2.8K in other compensation.

Rankings

In 2016, Matthew Ros' compensation ranked 6,192nd out of 14,075 executives tracked by ExecPay. In other words, Ros earned more than 56.0% of executives.

ClassificationRankingPercentile
All
6,192
out of 14,075
56th
Division
Manufacturing
2,272
out of 5,486
59th
Major group
Chemicals And Allied Products
748
out of 1,900
61st
Industry group
Drugs
567
out of 1,543
63rd
Industry
Pharmaceutical Preparations
444
out of 1,173
62nd
Source: SEC filing on April 18, 2019.

Ros' colleagues

We found four more compensation records of executives who worked with Matthew Ros at Epizyme in 2016.

2016

Robert Bazemore

Epizyme

Chief Executive Officer

2016

Robert Bazemore

Epizyme

Chief Executive Officer

2016

Andrew Singer

Epizyme

Chief Financial Officer

2016

Robert Copeland

Epizyme

Chief Scientific Officer

News

In-depth

You may also like